Lonza (Basel, Switzerland) reports major increases in earnings and revenue in the first half of the year and has upgraded its sales forecast for the whole of 2018. Core EBITDA grew 40.7% to 802 million Swiss francs ($807.9 million) and core EBITDA margin advanced from 24.7% in the first half of 2017 to 26.0% in the corresponding period of this year. Sales were up 33.3% to SFr3.08 billion; this achievement comes one year after closing of the Capsugel acquisition.
展开▼
